You are here

Home Projects Licensing Opportunities Small Molecules

Small Molecules

Search our small molecule opportunities against novel cancer targets and pathways. We have drug discovery, pre-clinical and clinical stage opportunities available for co-development and/or licensing.

Novel dual inhibitors of FLT3 and Aurora Kinases

We are seeking a co-development or licensing partner to take this Clinical Development Candidate into Phase I clinical studies.

 Read more
First-in-Class IKK Alpha Selective Compounds

We are seeking a co-development or licensing partner to drive candidate selection and entry into formal pre-clinical studies.

 Read more
Novel FAK-selective Inhibitors

Small Molecules - In Vivo Proof of Principle

 Read more
Novel FLT3-FAK-VEGFR3 Triple Kinase Inhibitors

We are seeking prospective commercial partners with an interest in global therapeutic rights to the FLT3-FAK-VEGFR3 triple kinase inhibitor programme on an exclusive basis.

 Read more
Chk2 Inhibitor Programme

We are seeking a commercial partner interested in pursuing a co-development or direct licensing arrangement.

 Read more